Respiratory News and Research

RSS

Study: Severe C. difficile infections occur among children who prescribed antibiotics in doctor's offices

The majority of pediatric Clostridium difficile infections, which are bacterial infections that cause severe diarrhea and are potentially life-threatening, occur among children in the general community who recently took antibiotics prescribed in doctor's offices for other conditions, according to a new study by the Centers for Disease Control and Prevention published this week in Pediatrics.

10 Mar 2014

Edison Pharmaceuticals initiates Phase 2B/3 study of EPI-743 in children with Leigh syndrome

Edison Pharmaceuticals today announced the initiation of a phase 2B/3 study entitled, "A Phase 2B/3 Open-label Study of EPI-743 in Children with Leigh Syndrome" to be conducted in conjunction with Dainippon Sumitomo Pharma Co, Ltd.

10 Mar 2014

Teva launches generic Xeloda Tablets in the U.S.

Teva Pharmaceutical Industries Ltd. announces the launch of the generic equivalent to Xeloda (Capecitabine) Tablets, 150 MG and 500 MG, in the United States. Xeloda is marketed by Genentech in the United States.

8 Mar 2014

Higher levels of exposure to traffic-related air pollution linked to changes in right ventricle of the heart

Exposure to high levels of traffic-related air pollution is associated with changes in the right ventricle of the heart that may contribute to the known connection between air pollution exposure and heart disease, according to a new study.

7 Mar 2014

Groups, insurers, officials mobilize for health law enrollment push

March 31 is the deadline for signing up for insurance, and young adults and minorities are among the groups being targeted.

7 Mar 2014

Researchers find 69% rise in pertussis vaccination rate among new mothers

Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.

6 Mar 2014

Treating cystic fibrosis: an interview with Simon Bedson, Senior Vice President and International General Manager at Vertex

Cystic fibrosis is a rare, life-shortening genetic disease for which there is no cure. It affects more than 75,000 people worldwide. In CF, thick, sticky mucus blocks the passages in many organs, leading to a variety of symptoms. In particular, mucus builds up and clogs airways in the lungs making it easier for bacteria to grow.

5 Mar 2014

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

5 Mar 2014

Computational Fluid Dynamics helps patients with pulmonary disorders breathe easier

A more accurate and successful, yet complex approach used in designing an airplane is now taking off in the health care industry.

5 Mar 2014

Study: 55% of women are passive smokers due to exposure to tobacco smoke

As shown in a study carried out by researchers at 13 research centres in Asturias, Gipuzkoa, Sabadell and Valencia, over half of non-smoking pregnant women, 55%, are passive smokers.

5 Mar 2014

Cell-cycle arrest biomarkers validated for acute kidney injury

Saeed A. Jortani, Ph.D., associate clinical professor in the University of Louisville's Department of Pathology and Laboratory Medicine, headed up one of three labs in the United States involved in determining two new markers for acute kidney injury (AKI). The research group's paper, "Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication," was posted online Feb. 25 by the American Journal of Respiratory and Critical Care Medicine.

5 Mar 2014

Merck reports results from Phase 2b study of investigational house dust mite sublingual immunotherapy tablet

Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.

5 Mar 2014

Cancer contributes to schizophrenia mortality

Study findings confirm the increased risk of death from physical diseases among patients with schizophrenia, and reveal cancer mortality as an issue among middle-aged patients.

4 Mar 2014

Covidien's Puritan Bennett 980 ventilator receives CE Mark approval

Covidien plc, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its Puritan Bennett 980 ventilator has received European Economic Area CE Mark approval.

3 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting , San Diego, California, USA on March 1st.

3 Mar 2014

Respiratory News and Research

Study: Severe C. difficile infections occur among children who prescribed antibiotics in doctor's offices

Edison Pharmaceuticals initiates Phase 2B/3 study of EPI-743 in children with Leigh syndrome

Teva launches generic Xeloda Tablets in the U.S.

Higher levels of exposure to traffic-related air pollution linked to changes in right ventricle of the heart

Groups, insurers, officials mobilize for health law enrollment push

Researchers find 69% rise in pertussis vaccination rate among new mothers

Treating cystic fibrosis: an interview with Simon Bedson, Senior Vice President and International General Manager at Vertex

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

Computational Fluid Dynamics helps patients with pulmonary disorders breathe easier

Study: 55% of women are passive smokers due to exposure to tobacco smoke

Cell-cycle arrest biomarkers validated for acute kidney injury

Merck reports results from Phase 2b study of investigational house dust mite sublingual immunotherapy tablet

Cancer contributes to schizophrenia mortality

Covidien's Puritan Bennett 980 ventilator receives CE Mark approval

New article explores risks associated with using herbal cannabis for rheumatic conditions

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Scientists map key elements of immune overreaction triggered by influenza virus infection

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

High-carbohydrate, high-calorie diet could delay progression of Amyotrophic Lateral Sclerosis

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News